Asemptomatik kreatin kinaz (CK) yüksekliği: Hiper-CK-emi
Year 2020,
Volume: 45 Issue: 2, 756 - 757, 30.06.2020
Oğuz Abdullah Uyaroğlu
Supporting Institution
Yok
References
- 1. Moghadam-Kia S, Oddis CV, Aggarwal R. Approach to asymptomatic creatine kinase elevation. Cleve Clin J Med. 2016 Jan;83(1):37-42. doi: 10.3949/ccjm.83a.14120. Review. PubMed PMID: 26760521; PubMed Central PMCID: PMC4871266.
- 2. Kyriakides T, Angelini C, Schaefer J, et al. European Federation of Neurological Societies. EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. Eur J Neurol. 2010; 17:767–773. [PubMed: 20402744]
- 3. Lilleng H, Abeler K, Johnsen SH, et al. Variation of serum creatine kinase (CK) levels and prevalence of persistent hyperCKemia in a Norwegian normal population. The Tromsø Study. Neuromuscul Disord. 2011; 21:494–500. [PubMed: 21592795]
Asymptomatic creatine kinase (CK) elevation: Hyper-CK-emia
Year 2020,
Volume: 45 Issue: 2, 756 - 757, 30.06.2020
Oğuz Abdullah Uyaroğlu
References
- 1. Moghadam-Kia S, Oddis CV, Aggarwal R. Approach to asymptomatic creatine kinase elevation. Cleve Clin J Med. 2016 Jan;83(1):37-42. doi: 10.3949/ccjm.83a.14120. Review. PubMed PMID: 26760521; PubMed Central PMCID: PMC4871266.
- 2. Kyriakides T, Angelini C, Schaefer J, et al. European Federation of Neurological Societies. EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. Eur J Neurol. 2010; 17:767–773. [PubMed: 20402744]
- 3. Lilleng H, Abeler K, Johnsen SH, et al. Variation of serum creatine kinase (CK) levels and prevalence of persistent hyperCKemia in a Norwegian normal population. The Tromsø Study. Neuromuscul Disord. 2011; 21:494–500. [PubMed: 21592795]
There are 3 citations in total.